Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byC. R. Bard
Date10/2012

General Information

Websiteneomend.com
CategoryBioTech
Phone949-916-1630
Emailcustomerservice@n...
Employees
Founded1999

Offices

Irvine, USA
60 Technology Drive
Irvine, CA, 92618
USA

People

President & CEO
Board of Directors

Funding

TOTAL $50M
FUNDING TOTAL $50M
Series D, 1/2010
Clarus Ventures
Sanderling Ventures
Novo Ventures
Vivo Ventures
Prospect Venture Partners
$30M
Series D, 8/2011
$20M
DEBT TOTAL $5.7M
Debt, 5/2009
$2.7M
Debt, 10/2009
$3M

Tags

Neomend

Neomend, Inc., a biomedical device company, engages in the development and commercialization of surgical wound healing products. Its platform technology, Pro/PEG, is a bioadhesive polymer hydrogel. NeoMend engages in commercialization of the combination wound sealant and adhesion barrier product that can be delivered during minimally invasive/laparoscopic procedures. Neomend, Inc. was founded in 1999 and is based in Irvine, California.

Recent Milestones

Videos

Screenshots

Neomend screenshot
Above: Home Page
Uploaded: 1/28/10

Sources

  1. C.R. Bard Acquires Neomend (pevc.dowjones.com) [edit]
  2. SEC (sec.gov) [edit]
  3. SEC (sec.gov) [edit]
  4. Neomend Closes $30M Funding Round (finsmes.com) [edit]
  5. Surgical Sealant Maker NeoMend Adds $20M To Series D Round (fis.dowjones.com) [edit]
Edit This Page
Last Edited 3/13/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy